OptimizeRx Corporation
OPRX
$5.12
$0.224.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.84M | 5.13M | 34.00K | -9.87M | -15.41M |
| Total Depreciation and Amortization | 4.39M | 4.42M | 4.42M | 4.43M | 4.43M |
| Total Amortization of Deferred Charges | 1.20M | 1.02M | 993.00K | 1.01M | 756.00K |
| Total Other Non-Cash Items | 7.60M | 7.33M | 8.02M | 16.15M | 17.57M |
| Change in Net Operating Assets | -5.64M | 816.00K | -1.64M | -1.31M | -704.00K |
| Cash from Operations | 14.38M | 18.72M | 11.83M | 10.41M | 6.64M |
| Capital Expenditure | -52.00K | -58.00K | -64.00K | -72.00K | -107.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 183.00K | 126.00K | -194.00K | -268.00K | -274.00K |
| Cash from Investing | 131.00K | 68.00K | -258.00K | -340.00K | -381.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.19M | -8.00M | -8.00M | -8.00M | -4.00M |
| Issuance of Common Stock | 352.00K | 352.00K | 338.00K | -- | -- |
| Repurchase of Common Stock | -1.08M | -1.15M | -512.00K | -448.00K | -858.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -10.92M | -8.80M | -8.17M | -8.45M | -4.86M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.60M | 9.99M | 3.39M | 1.63M | 1.40M |